14.55 | 11.55 – Panel Discussion: Starting With the End in Mind, Industry Collaboration for Industry Standards

Time: 2:55 pm
day: Day Two


  • How can the industry better work together to unpick and target tumor heterogeneity?
  • What can we learn from past successful Drug-Dx collaborations?
  • Collaborations and partnering to support regulatory submission pathways